Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study
- PMID: 40329232
- PMCID: PMC12054185
- DOI: 10.1186/s12886-025-04050-7
Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study
Abstract
Background: To explore the relationship among ocular surface changes, systemic hematologic indexes, and disease activity in primary Sjögren's syndrome patients.
Methods: Thirty-three primary Sjögren's syndrome patients and 36 healthy controls were recruited in this cross-sectional study. All participants underwent complete ocular surface testing, including dry eye symptoms and signs, tear multi-cytokine analysis, and conjunctival impression cytology (CIC). Multiple systemic hematologic indexes and disease activity were also evaluated, including autoantibodies, immune cells, the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), and the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI).
Results: Primary Sjögren's syndrome patients exhibited significant dry eye, severe conjunctivochalasis, decreased goblet cell density, and severe squamous epithelial on the ocular surface. Interferon-inducible T cell alpha chemoattractant (I-TAC), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1β, IL-5, IL-8, IL-10, IL-13, IL-21, C-C motif chemokine ligand (CCL)4, interferon-gamma (IFN-γ), CCL20, and tumor necrosis factor-gamma (TNF-α) in the tear fluid of pSS patients changed significantly. Correlation analysis showed that anti-SSA was relevant to ocular surface disease index (OSDI) score, tear break-up time (TBUT), and meibomian gland secretion (MGS). CD8+ T cell percentages were relevant to TBUT and corneal fluorescein staining score (CFS). IL-8, IL-13, CCL4, and TNF-α were correlated with RF-IgA. IL-1β, CCL4, and TNF-α were correlated with CD8+ T cell counts. IL-5 and CCL20 were correlated with the ratio of helper T cells and suppressor T cells. Tear I-TAC, IL-8, CCL20, and TNF-α were significantly correlated with the ESSDAI of different domains.
Conclusions: Our results revealed that the ocular surface changes in pSS patients were significantly correlated with systemic hematologic indexes and disease activity.
Keywords: Disease activity; Dry eye; Primary Sjögren’s syndrome; Tear cytokines.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All subjects participated in the program voluntarily and signed informed consent forms. The study obtained written informed consent from all enrolled patients, approved by the Ethics Committee of The Second Xiangya Hospital of Central South University (Ethics code, LYF2021028). This study strictly followed the Helsinki declaration, which was implemented to in ensuring the rights and safety of the subjects. Consent for publication: All authors read and approved the final manuscript before submission. Competing interests: The authors declare no competing interests.
Figures

Similar articles
-
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.Curr Eye Res. 1999 Sep;19(3):201-11. doi: 10.1076/ceyr.19.3.201.5309. Curr Eye Res. 1999. PMID: 10487957
-
Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.Arq Bras Oftalmol. 2019 Jan-Feb;82(1):45-50. doi: 10.5935/0004-2749.20190005. Epub 2018 Nov 1. Arq Bras Oftalmol. 2019. PMID: 30403265
-
A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren's syndrome patients with dry eye disease.Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):159-165. doi: 10.55563/clinexprheumatol/tlnr4z. Epub 2021 Sep 27. Clin Exp Rheumatol. 2021. PMID: 34596026
-
Tear cytokine levels in Sjogren's syndrome-related dry eye disease compared with non-Sjogren's syndrome-related dry eye disease patients: A meta-analysis.Medicine (Baltimore). 2024 Dec 6;103(49):e40669. doi: 10.1097/MD.0000000000040669. Medicine (Baltimore). 2024. PMID: 39654248 Free PMC article.
-
Outcome measures for primary Sjögren's syndrome: a comprehensive review.J Autoimmun. 2014 Jun;51:51-6. doi: 10.1016/j.jaut.2013.12.010. Epub 2014 Jan 8. J Autoimmun. 2014. PMID: 24411404 Review.
Cited by
-
Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications.Front Immunol. 2025 Jul 18;16:1604271. doi: 10.3389/fimmu.2025.1604271. eCollection 2025. Front Immunol. 2025. PMID: 40755762 Free PMC article. Review.
References
-
- Mavragani CP, Moutsopoulos HM. Sjogren’s syndrome: old and new therapeutic targets. J Autoimmun. 2020;110:102364. 10.1016/j.jaut.2019.102364 - PubMed
-
- Bowman SJ. Primary Sjögren’s syndrome. Lupus. 2018;27(1suppl):32–5. 10.1177/0961203318801673 - PubMed
-
- Akpek EK, Mathews P, Hahn S, Hessen M, Kim J, Grader-Beck T, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology. 2015;122(1):56–61. 10.1016/j.ophtha.2014.07.026 - PubMed
-
- Murube J. Primary and secondary Sjogren-Jones Syndromes—Historical evolution. Ocul Surf. 2011;9(1):13–. 10.1016/s1542-0124(11)70005-2. 6. - PubMed
-
- Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, et al. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015;13(2):118–32. 10.1016/j.jtos.2014.12.001 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous